Cite

HARVARD Citation

    Xu, S. et al. (2016). ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma. Cancer letters. 381 (1), pp. 41-48. [Online]. 
  
Back to record